First clinical experience with PSMA617

Slides:

Advertisements

Similar presentations

PicoSEC-MCNet TUM Activities Technische Universität München (TUM) Computer Aided Medical Procedures (CAMP) Tobias Reichl January 19, 2012.

Advertisements

Decreased Nuclear Receptor Activity Mediates Downregulation of Drug Metabolizing Enzymes in Chronic Kidney Disease Through Epigenetic Modulation October.

Carcinoma scarsamente differenziato Terapia radiorecettoriale

Motion correction in 3D PET/CT using optical flow methods M Dawood, F Büther, N Lang, X Jiang, M Schäfers, O Schober, KP Schäfers Nuclear Medicine, University.

1 MT vs CT: 28 day survival Number at risk CT MT day % Surviving Monotherapy.

Transforming Static CT in Gated PET/CT Studies to Multiple Respiratory Phases M Dawood, F Büther, N Lang, X Jiang, KP Schäfers Department of Nuclear Medicine,

3D Lung Segmentation on PET-CT Images Mohammad Dawood et al SNM 2005 Mohammad Dawood 1, Xioayi Jiang 2, Klaus P Schäfers 1, Ottmar Schober 1 1 Department.

Dr Richard J Owen – Interventional Radiology

Monitoring the radioimmunotherapeutic effect by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

References Adherence to follow-up CT scans in patients with small pulmonary nodules, a retrospective study Sofie Lock Johansson, Niels-Chr. G. Hansen Department.

177 Lu-Dota-NOCate & 177 Lu-Dota-Gastrin in Metastatic Medullary Thyroid Cancer Clinic of Endocrinology, Inst. of Nuclear Medicine, University Hospital,

Young Innovators 2009 Prostate-Specific Membrane Antigen (PSMA)-Targeted Imaging, Diagnosis, and Therapy of Prostate Cancer using a PSMA inhibitor as a.

Molecular Imaging “101” The Role of Molecular Imaging in Cancer Briefing and Roundtable Washington, DC July 22, 2008 Martin G. Pomper, MD, PhD Russell.

Choline PET/CT Robert S. Bridwell MD MBA Founder and CMO Appian 360

Nuclear imaging for prostate cancer: What’s new?

Volume 64, Issue 5, Pages (November 2013)

This program will include a discussion of investigational agents not approved by the FDA for use in the United States, and data that were presented in.

Klinikum rechts der Isar, Technische Universität München

Prostate cancer: Radioisotope diagnostic/ therapeutic methods

Imaging Techniques Used to Study Biological Systems

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer - DOI: / Fig. 1. Embolisation of the right.

Evolution of a “System” for Surgical Treatment of Adenocarcinomas

Nat. Rev. Urol. doi: /nrurol

Overview of Nuclear Technologies in Healthcare

WFNMB Post Congress Symposium Prostate Cancer: PET and Theranostics Cairns Convention Centre, Queensland, Australia April 26-27, 2018 THURSDAY 26th APRIL.

(A) Axial PET, (B) CT, (C) fused PET-CT, and (D) MIP images of a 68-year-old male with metastatic prostate cancer demonstrating diffuse sodium fluoride.

New Tracers for Prostate Cancer Imaging

Erica V. Bloomquist, MD Heather Wright, MD

Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate.

Categorisation of direct and indirect admissions to the intensive care unit (ICU) from emergency departments (EDs), using source of admission. Categorisation.

Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma – Is PSMA-PET-CT a helpful tool in radiation oncology? Laila König, Henrik.

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Volume 73, Issue 5, Pages (May 2018)

Managing Nonmetastatic Castration-resistant Prostate Cancer

A Case Report Demonstrating the Potential Clinical Benefit of Exhaustive Molecular Profiling in an Aggressive Muscle-Invasive High-Grade Metastatic Urothelial.

Bladder Cancer: A Major Public Health Issue

Volume 64, Issue 5, Pages (November 2013)

Updates in Detection and Management of BCRPC

Brief Introduction of Nuclear Medicine in China

Nat. Rev. Urol. doi: /nrurol

Integrated positron emission tomography (PET)/computed tomography (CT)

Veterinary medicine's increasing role in global health

A 30-year-old man with PSA

Label Name Label Name Label Name Label Name Label Name Label Name

Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.

Axial CT image of the lower abdomen obtained after the administration of intravenous iodinated contrast reveals injection of the paracolic fat extending.

Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma – Is PSMA-PET-CT a helpful tool in radiation oncology? Laila König, Henrik.

Figure 2 Carotid artery inflammation detected using 68Ga-DOTATATE-PET

Nat. Rev. Urol. doi: /nrurol

Metabolic response by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT). a) FDG PET/CT for patient 2 at baseline.

European Urology Oncology

Elements of Vietnam’s HIV/AIDS patient monitoring system as of 31 December 2016 (adapted from 2016 National HIV/AIDS Report10). ART, antiretroviral therapy;

Figure 5 Schematic overview of a clinical decision-support

The number of prescriptions of pharmaceutical subcategories between July 1, 2008 and November 30, 2011. The number of prescriptions of pharmaceutical subcategories.

Catherine M. Pound et al. Hospital Pediatrics 2017;7:

Low-Energy and Low-Tube-Current CT for Positive Oral Contrast Media in Patients with Cancer: A Randomized Clinical Trial At low tube current or low energy.

Improving management of neonatal infections

A) Axial, 5-mm slice thickness computed tomography (CT) image through the upper lobes at the level of the aortic arch. a) Axial, 5-mm slice thickness computed.

Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:

Bowel gas displacement II

Victor A. Ferrari et al. JIMG 2014;7:

Fig. 4 PSMA PET/CT enables visualization of CD19-tPSMA(N9del) CAR T cell infiltration into local and metastatic tumors. PSMA PET/CT enables visualization.

A, CT myelogram and myelogram showing minimal filling of a large right S2 Tarlov cyst with a narrow neck. A, CT myelogram and myelogram showing minimal.

Micro-PET/CT images of 64Cu-Sar-chTNT-3 in MAD109-bearing BALB/c mice following VP-16 pretreatment. Micro-PET/CT images of 64Cu-Sar-chTNT-3 in MAD109-bearing.

PSMA expression in pre- and posttreatment prostate carcinoma serum.

Transgenic mice with constitutively active NIK show increased tumor growth in bone. Transgenic mice with constitutively active NIK show increased tumor.

An average of 20% of postpartum women chose long acting contraception post-intervention between April 2016 and July 2017, compared to 5% pre-intervention,

Compliance with empiric therapy guidelines for treatment of each type of pneumonia. Compliance with empiric therapy guidelines for treatment of each type.

Small bowel obstruction due to obstructed obturator hernia.

Presentation transcript:

First clinical experience with PSMA617 Radioph. Chem. First clinical experience with PSMA617 First human PET/CT imaging 68Ga-labeled PSMA617 CT 1 h post injection CT PET/CT PET/CT PSMA617 MIP PSA level 0.7 Afshar-Oromieh, Kratochwil et al., Department of Nuclear Medicine, University Hospital Heidelberg 1

First clinical experience with PSMA617 Radioph. Chem. First clinical experience with PSMA617 First human therapy with 177Lu-labeled PSMA617 3,3 GBq Imaging 68Ga-11-HBED-CC December 13 40 PSA [µg/l] 3,3 GBq 177Lu-617 03.02.14 4,0 GBq 4,0 GBq 177Lu-617 05.05.14 8 Imaging 68Ga-11-HBED-CC July 14 PSA level 14 PSA level 38 PSA level 8 Afshar-Oromieh, Kratochwil et al., Department of Nuclear Medicine, University Hospital Heidelberg